Post by Takeda Oncology

There are many driver mutations that could be associated with non-small cell lung cancer (NSCLC), making it complex to study, diagnose and treat.  Knowing what differentiates ALK+ NSCLC from other forms of NSCLC is essential to understanding and supporting this community. Explore our resources to learn more: https://lnkd.in/exJX2q_H